GetTopicDetailResponse(id=3c69124228fe, topicName=Pegloticase, introduction=, content=甲氨蝶呤 痛風 Pegloticase, image=null, comments=0, allHits=350, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Feb 15 07:12:57 CST 2025, time=2025-02-15, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501449, tagList=[TagDto(tagId=501449, tagName=Pegloticase)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2267132, encodeId=1cc1226e132a0, content=<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛風#</a> <a href='/topic/show?id=3c69124228fe' target=_blank style='color:#2F92EE;'>#Pegloticase#</a>, objectTitle=Rheumatology (Oxford)：聚乙二醇重組尿酸酶治療痛風，心血管與血栓事件風險及痛風發(fā)作時間關聯(lián)性研究, objectType=article, longId=879631, objectId=b9c08e96312e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721282756373_92910.jpg, objectUrl=/article/show_article.do?id=b9c08e96312e, replyNumber=0, likeNumber=28, createdTime=2025-05-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b9c08e96312e, moduleTitle=Rheumatology (Oxford)：聚乙二醇重組尿酸酶治療痛風，心血管與血栓事件風險及痛風發(fā)作時間關聯(lián)性研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b9c08e96312e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2252001, encodeId=348022520011e, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛風#</a> <a href='/topic/show?id=3c69124228fe' target=_blank style='color:#2F92EE;'>#Pegloticase#</a>, objectTitle=ACR Open Rheumatol：Pegloticase聯(lián)合甲氨蝶呤治療以往單藥治療失敗的痛風患者的療效與安全性, objectType=article, longId=863199, objectId=76f78631996c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250213/1739459084149_5485250.png, objectUrl=/article/show_article.do?id=76f78631996c, replyNumber=0, likeNumber=42, createdTime=2025-02-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=76f78631996c, moduleTitle=ACR Open Rheumatol：Pegloticase聯(lián)合甲氨蝶呤治療以往單藥治療失敗的痛風患者的療效與安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=76f78631996c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-15發(fā)表于威斯康星
